Malondialdehyde (MDS) re-appearance in human platelet density subpopulations after a single intake of aspirin - PubMed (original) (raw)

Malondialdehyde (MDS) re-appearance in human platelet density subpopulations after a single intake of aspirin

B Boneu et al. Thromb Res. 1980.

No abstract available

Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
Szczeklik A, Gryglewski RJ, Grodzińska L, Musiał J, Serwońska M, Marcinkiewicz E. Szczeklik A, et al. Thromb Res. 1979;15(3-4):405-13. doi: 10.1016/0049-3848(79)90147-6. Thromb Res. 1979. PMID: 494154 No abstract available.
Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB, Ingerman CM, Silver MJ. Smith JB, et al. J Lab Clin Med. 1976 Jul;88(1):167-72. J Lab Clin Med. 1976. PMID: 932533
In vivo measurement of platelet activity in postoperative patients.
Stulberg BN, Weksler BB, Ranawat CS. Stulberg BN, et al. Surg Forum. 1979;30:489-91. Surg Forum. 1979. PMID: 538672 No abstract available.
The neonatal platelet: evaluation of platelet malonyl dialdehyde formation as an indicator of prostaglandin synthesis.
Stuart MJ. Stuart MJ. Br J Haematol. 1978 May;39(1):83-90. doi: 10.1111/j.1365-2141.1978.tb07130.x. Br J Haematol. 1978. PMID: 666980 No abstract available.
[Effect of hydralazine on the formation of malondialdehyde in platelet-rich plasma and aortic rings in the rat].
Cano E, Orallo F, Cadavid I. Cano E, et al. Arch Farmacol Toxicol. 1986 Apr;12(1):49-55. Arch Farmacol Toxicol. 1986. PMID: 3090953 Spanish. No abstract available.

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd, Lawson JA, Brash AR. FitzGerald GA, et al. J Clin Invest. 1983 Mar;71(3):676-88. doi: 10.1172/jci110814. J Clin Invest. 1983. PMID: 6338043 Free PMC article.